866-997-4948(US-Canada Toll Free)

Diagnostic Specialty Antibodies Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Published By :

Transparency Market Research

Published Date : Dec 2018

Category :

Healthcare

No. of Pages : 175 Pages

Global Diagnostic Specialty Antibodies Market: Overview

Antibody is a blood protein produced in response to a specific antigen. An antibody is also known as immunoglobulin and is generally Y-shaped in structure. Advances in genetic engineering have made antibodies, especially monoclonal antibodies, more robust and efficacious as these increase the binding capacity to any type of specific antigen and are quite effective as a diagnostics tool to evaluate the various infectious diseases. However, demand for Diagnostic Specialty Antibodies is anticipated to decline during the forecast period owing to failure of antibodies in rapid diagnostic test for routine diagnosis and high cost of monoclonal antibodies.

The global diagnostic specialty antibodies market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on antibody type, application, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global diagnostic specialty antibodies market.

Global Diagnostic Specialty Antibodies Market: Key Segments

In terms of antibody type, the global diagnostic specialty antibodies market has been segmented into monoclonal antibodies, polyclonal antibodies, and recombinant polyclonal antibodies. Based on application, the market has been classified into hepatitis diagnosis, tuberculosis diagnostics, dengue diagnostics, oncology diagnostics, HIV diagnostics, infectious disease diagnostics, and others. In terms of end-user, the global diagnostic specialty antibodies market has been categorized into hospitals, diagnostic laboratories, and others. The market has been analyzed based on price variations, technology trend, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Diagnostic Specialty Antibodies Market: Regional Outlook

Geographically, the global diagnostic specialty antibodies market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa and GCC Countries). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles the major players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the report are F. Hoffmann-La Roche AG, Sanofi, Abbott Laboratories, Abcam plc, Bio-Rad Laboratories, Inc., Boehringer Ingelheim International GmbH, Agilent Technologies, Inc., and Aytu BioScience, Inc., among others.

The global diagnostic specialty antibodies market has been segmented as follows:

Global Diagnostic Specialty Antibodies Market, by Antibody Type

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Polyclonal Antibodies

Global Diagnostic Specialty Antibodies Market, by Application

  • Hepatitis Diagnosis
  • Tuberculosis Diagnostics
  • Dengue Diagnostics
  • Oncology Diagnostics
  • HIV Diagnostics
  • Infectious Disease Diagnostics
  • Others

Global Diagnostic Specialty Antibodies Market, by End-user

  • Hospitals
  • Diagnostic Laboratories
  • Others

Global Diagnostic Specialty Antibodies Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia & New Zealand
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Rest of Middle East & Africa

Table of Content

1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
1.3. Assumptions and Acronyms Used

2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Key Industry Evolution/Developments
4.3. Overview: Global Diagnostic Specialty Antibodies Market
4.4. Market Dynamics
4.4.1. Drivers
4.4.1.1. Surge in government investment in diagnostic health care
4.4.1.2. Increase in launch of new, innovative biologic diagnostic kits
4.4.2. Restraints
4.4.2.1. Failure of antibodies in rapid diagnostic test for routine diagnosis
4.4.2.2. High cost of monoclonal antibodies
4.4.3. Opportunities
4.4.3.1. Expansion into emerging markets
4.5. Technological Assessment
4.6. Pipeline Analysis: Diagnostic Specialty Antibody
4.7. Patent Filling Details of Various Diagnostic Antibody
4.8. Regulatory Framework

5. Global Diagnostic Specialty Antibodies Market, by Antibody Type
5.1. Introduction and Definitions
5.2. Key Findings
5.3. Global Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type
5.4. Global Diagnostic Specialty Antibodies Market Size & Forecast, by Antibody Type
5.4.1. Monoclonal Antibodies
5.4.2. Polyclonal Antibodies
5.4.3. Recombinant Polyclonal Antibodies
5.5. Global Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type

6. Global Diagnostic Specialty Antibodies Market, by Application
6.1. Introduction and Definitions
6.2. Key Findings
6.3. Global Diagnostic Specialty Antibodies Market Value Share Analysis, by Application
6.3.1. Global Diagnostic Specialty Antibodies Market Size & Forecast, by Application
6.3.2. Hepatitis Diagnosis
6.3.3. Tuberculosis Diagnostics
6.3.4. Dengue Diagnostics
6.3.5. Oncology Diagnostics
6.3.6. HIV Diagnostics
6.3.7. Infectious Disease Diagnostics
6.3.8. Others
6.4. Global Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application

7. Global Diagnostic Specialty Antibodies Market, by End-user
7.1. Introduction and Definitions
7.2. Key Findings
7.3. Global Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user
7.3.1. Global Diagnostic Specialty Antibodies Market Size & Forecast, by End-user
7.3.2. Hospitals
7.3.3. Diagnostic Laboratories
7.3.4. Others
7.4. Global Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user

8. Global Diagnostic Specialty Antibodies Market, by Region
8.1. Introduction and Definitions
8.2. Key Findings
8.3. Global Diagnostic Specialty Antibodies Market Value Share Analysis, by Region
8.3.1. Global Diagnostic Specialty Antibodies Market Size & Forecast, by Region
8.3.2. North America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Latin America
8.3.6. Middle East & Africa
8.4. Global Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Region

9. North America Diagnostic Specialty Antibodies Market, by Region
9.1. Key Findings
9.2. North America Diagnostic Specialty Antibodies Market Value Share Analysis, by Country
9.3. North America Diagnostic Specialty Antibodies Market Value Forecast, by Country
9.3.1. U.S.
9.3.2. Country
9.4. North America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Country
9.5. North America Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type
9.6. North America Diagnostic Specialty Antibodies Market Value Forecast, by Antibody Type
9.6.1. Monoclonal Antibodies
9.6.2. Polyclonal Antibodies
9.6.3. Recombinant Polyclonal Antibodies
9.7. North America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type
9.8. North America Diagnostic Specialty Antibodies Market Value Share Analysis, by Application
9.9. North America Diagnostic Specialty Antibodies Market Value Forecast, by Application
9.9.1. Hepatitis Diagnosis
9.9.2. Tuberculosis Diagnostics
9.9.3. Dengue Diagnostics
9.9.4. Oncology Diagnostics
9.9.5. HIV Diagnostics
9.9.6. Infectious Disease Diagnostics
9.9.7. Others
9.10. North America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application
9.11. North America Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user
9.12. North America Diagnostic Specialty Antibodies Market Value Forecast, by End-user
9.12.1. Hospitals
9.12.2. Diagnostic Laboratories
9.12.3. Others
9.13. North America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user

10. Europe Diagnostic Specialty Antibodies Market, by Region
10.1. Key Findings
10.2. Europe Diagnostic Specialty Antibodies Market Value Share Analysis, by Country/Sub-region
10.3. Europe Diagnostic Specialty Antibodies Market Value Forecast, by Country/Sub-region
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Spain
10.3.5. Italy
10.3.6. Rest of Europe
10.4. Europe Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Country/Sub-region
10.5. Europe Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type
10.6. Europe Diagnostic Specialty Antibodies Market Value Forecast, by Antibody Type
10.6.1. Monoclonal Antibodies
10.6.2. Polyclonal Antibodies
10.6.3. Recombinant Polyclonal Antibodies
10.7. Europe Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type
10.8. Europe Diagnostic Specialty Antibodies Market Value Share Analysis, by Application
10.9. Europe Diagnostic Specialty Antibodies Market Value Forecast, by Application
10.9.1. Hepatitis Diagnosis
10.9.2. Tuberculosis Diagnostics
10.9.3. Dengue Diagnostics
10.9.4. Oncology Diagnostics
10.9.5. HIV Diagnostics
10.9.6. Infectious Disease Diagnostics
10.9.7. Others
10.10. Europe Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application
10.11. Europe Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user
10.12. Europe Diagnostic Specialty Antibodies Market Value Forecast, by End-user
10.12.1. Hospitals
10.12.2. Diagnostic Laboratories
10.12.3. Others
10.13. Europe Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user

11. Asia Pacific Diagnostic Specialty Antibodies Market, by Region
11.1. Key Findings
11.2. Asia Pacific Diagnostic Specialty Antibodies Market Value Share Analysis, by Country/Sub-region
11.3. Asia Pacific Diagnostic Specialty Antibodies Market Value Forecast, by Country/Sub-region
11.3.1. China
11.3.2. Japan
11.3.3. India
11.3.4. Australia & New Zealand
11.3.5. Rest of Asia Pacific
11.4. Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Country/Sub-region
11.5. Asia Pacific Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type
11.6. Asia Pacific Diagnostic Specialty Antibodies Market Value Forecast, by Antibody Type
11.6.1. Monoclonal Antibodies
11.6.2. Polyclonal Antibodies
11.6.3. Recombinant Polyclonal Antibodies
11.7. Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type
11.8. Asia Pacific Diagnostic Specialty Antibodies Market Value Share Analysis, by Application
11.9. Asia Pacific Diagnostic Specialty Antibodies Market Value Forecast, by Application
11.9.1. Hepatitis Diagnosis
11.9.2. Tuberculosis Diagnostics
11.9.3. Dengue Diagnostics
11.9.4. Oncology Diagnostics
11.9.5. HIV Diagnostics
11.9.6. Infectious Disease Diagnostics
11.9.7. Others
11.10. Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application
11.11. Asia Pacific Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user
11.12. Asia Pacific Diagnostic Specialty Antibodies Market Value Forecast, by End-user
11.12.1. Hospitals
11.12.2. Diagnostic Laboratories
11.12.3. Others
11.13. Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user

12. Latin America Diagnostic Specialty Antibodies Market, by Region
12.1. Key Findings
12.2. Latin America Diagnostic Specialty Antibodies Market Value Share Analysis, by Country/Sub-region
12.3. Latin America Diagnostic Specialty Antibodies Market Value Forecast, by Country/Sub-region
12.3.1. Brazil
12.3.2. Mexico
12.3.3. Rest of Latin America
12.4. Latin America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Country/Sub-region
12.5. Latin America Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type
12.6. Latin America Diagnostic Specialty Antibodies Market Value Forecast, by Antibody Type
12.6.1. Monoclonal Antibodies
12.6.2. Polyclonal Antibodies
12.6.3. Recombinant Polyclonal Antibodies
12.7. Latin America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type
12.8. Latin America Diagnostic Specialty Antibodies Market Value Share Analysis, by Application
12.9. Latin America Diagnostic Specialty Antibodies Market Value Forecast, by Application
12.9.1. Hepatitis Diagnosis
12.9.2. Tuberculosis Diagnostics
12.9.3. Dengue Diagnostics
12.9.4. Oncology Diagnostics
12.9.5. HIV Diagnostics
12.9.6. Infectious Disease Diagnostics
12.9.7. Other Diagnostics
12.10. Latin America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application
12.11. Latin America Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user
12.12. Latin America Diagnostic Specialty Antibodies Market Value Forecast, by End-user
12.12.1. Hospitals
12.12.2. Diagnostic Laboratories
12.12.3. Others
12.13. Latin America Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user

13. Middle East & Africa Diagnostic Specialty Antibodies Market, by Region
13.1. Key Findings
13.2. Middle East & Africa Diagnostic Specialty Antibodies Market Value Share Analysis, by Country/Sub-region
13.3. Middle East & Africa Diagnostic Specialty Antibodies Market Value Forecast, by Country/Sub-region
13.3.1. South Africa
13.3.2. GCC Countries
13.3.3. Rest of Middle East & Africa
13.4. Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Country/Sub-region
13.5. Middle East & Africa Diagnostic Specialty Antibodies Market Value Share Analysis, by Antibody Type
13.6. Middle East & Africa Diagnostic Specialty Antibodies Market Value Forecast, by Antibody Type
13.6.1. Monoclonal Antibodies
13.6.2. Polyclonal Antibodies
13.6.3. Recombinant Polyclonal Antibodies
13.7. Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Antibody Type
13.8. Middle East & Africa Diagnostic Specialty Antibodies Market Value Share Analysis, by Application
13.9. Middle East & Africa Diagnostic Specialty Antibodies Market Value Forecast, by Application
13.9.1. Hepatitis Diagnosis
13.9.2. Tuberculosis Diagnostics
13.9.3. Dengue Diagnostics
13.9.4. Oncology Diagnostics
13.9.5. HIV Diagnostics
13.9.6. Infectious Disease Diagnostics
13.9.7. Others
13.10. Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness Analysis, by Application
13.11. Middle East & Africa Diagnostic Specialty Antibodies Market Value Share Analysis, by End-user
13.12. Middle East & Africa Diagnostic Specialty Antibodies Market Value Forecast, by End-user
13.12.1. Hospitals
13.12.2. Diagnostic Laboratories
13.12.3. Others
13.13. Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness Analysis, by End-user

14. Company Profiles
14.1.1. Abcam plc
14.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.1.1.2. Financial Overview
14.1.1.3. Product Portfolio
14.1.1.4. SWOT Analysis
14.1.1.5. Strategic Overview
14.1.2. F. Hoffmann-La Roche AG
14.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.1.2.2. Financial Overview
14.1.2.3. Product Portfolio
14.1.2.4. SWOT Analysis
14.1.2.5. Strategic Overview
14.1.3. Sanofi
14.1.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.1.3.2. Financial Overview
14.1.3.3. Product Portfolio
14.1.3.4. SWOT Analysis
14.1.3.5. Strategic Overview
14.1.4. Abbott Laboratories
14.1.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.1.4.2. Financial Overview
14.1.4.3. Product Portfolio
14.1.4.4. SWOT Analysis
14.1.4.5. Strategic Overview
14.1.5. Bio-Rad Laboratories, Inc.
14.1.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.1.5.2. Financial Overview
14.1.5.3. Product Portfolio
14.1.5.4. SWOT Analysis
14.1.5.5. Strategic Overview
14.1.6. Boehringer Ingelheim International GmbH
14.1.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.1.6.2. Financial Overview
14.1.6.3. Product Portfolio
14.1.6.4. SWOT Analysis
14.1.6.5. Strategic Overview
14.1.7. Agilent Technologies, Inc.
14.1.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.1.7.2. Financial Overview
14.1.7.3. Product Portfolio
14.1.7.4. SWOT Analysis
14.1.7.5. Strategic Overview
14.1.8. Aytu BioScience, Inc.
14.1.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.1.8.2. Financial Overview
14.1.8.3. Product Portfolio
14.1.8.4. SWOT Analysis
14.1.8.5. Strategic Overview

List of Table

Table 01: Pipeline Analysis of Diagnostic Specialty Antibodies (1/2)
Table 02: Pipeline Analysis of Diagnostic Specialty Antibodies (2/2)
Table 03: Global Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Antibody Type, 2016–2026
Table 04: Global Diagnostic Specialty Antibodies Market Size (US$ Mn) Forecast, by Application, 2016–2026
Table 05: Global Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 06: Global Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 07: North America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 08: North America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Antibody Type, 2016–2026
Table 09: North America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 10: North America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 11: Europe Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016–2026
Table 12: Europe Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Antibody Type, 2016–2026
Table 13: Europe Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 14: Europe Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 15: Asia Pacific Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Country/ Sub-Region, 2016–2026
Table 16: Asia Pacific Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Antibody Type, 2016–2026
Table 17: Asia Pacific Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 18: Asia Pacific Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 19: Latin America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 20: Latin America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Antibody Type, 2016–2026
Table 21: Latin America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 22: Latin America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 23: Middle East & Africa Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 24: Middle East & Africa Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Antibody Type, 2016–2026
Table 25: Middle East & Africa Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by Application, 2016–2026
Table 26: Middle East & Africa Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, by End-user, 2016–2026

List of Chart

Figure 01: Global Diagnostic Specialty Antibodies Market Size (US$ Mn) and Distribution, by Region, 2018 and 2026
Figure 02: Market Snapshot of Global Diagnostic Specialty Antibodies Market 
Figure 03: Market Opportunity Map, Revenue Share, by Antibody Type
Figure 04: Market Opportunity Map, Revenue Share, by Application
Figure 05: Recent Key Industry Events of Diagnostic Specialty Antibodies Market 
Figure 06: Global Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast, 2016–2026
Figure 07: Market Value Share, by End-user, 2017
Figure 08: Market Value Share, by Antibody Type, 2017
Figure 09: Market Value Share, by Region, 2017
Figure 10: Market Value Share, by Application, 2017
Figure 11: Patent Filling Details of Various Diagnostic Antibody
Figure 12: Patent Filling Details of Various Diagnostic Antibody
Figure 13: Patent Filling Details of Various Diagnostic Antibody
Figure 14: Global Diagnostic Specialty Antibodies Market Value Share, by Antibody Type, 2018 and 2026
Figure 15: Global Diagnostic Specialty Antibodies Market Attractiveness, by Antibody Type, 2018–2026
Figure 16: Global Monoclonal Antibodies Market Revenue
Figure 17: Global Polyclonal Antibodies Market Revenue
Figure 18: Global Recombinant Polyclonal Antibodies Market Revenue
Figure 19: Global Diagnostic Specialty Antibodies Market Value Share, by Application, 2018 and 2026
Figure 20: Global Diagnostic Specialty Antibodies Market Attractiveness, by Application, 2018–2026
Figure 21: Global Hepatitis Diagnosis Specialty Antibody Market Revenue
Figure 22: Global Tuberculosis Diagnostics Specialty Antibody Market Revenue
Figure 23: Global Dengue Diagnostics Specialty Antibody Market Revenue
Figure 24: Global Oncology Diagnostics Specialty Antibody Market Revenue
Figure 25: Global HIV Diagnostics Specialty Antibody Market Revenue
Figure 26: Global Infectious Disease Diagnostics Specialty Antibody Market Revenue
Figure 27: Global Others Specialty Antibody Market Revenue
Figure 28: Global Diagnostic Specialty Antibodies Market Value Share, by End-user, 2018 and 2026
Figure 29: Global Diagnostic Specialty Antibodies Market Attractiveness, by End-user, 2018–2026
Figure 30: Global Diagnostic Specialty Antibodies Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2016–2026
Figure 31: Global Diagnostic Specialty Antibodies Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Laboratories, 2016–2026
Figure 32: Global Diagnostic Specialty Antibodies Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
Figure 32: Global Diagnostic Specialty Antibodies Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016–2026
Figure 33: Global Diagnostic Specialty Antibodies Market Value Share, by Region, 2018 and 2026
Figure 34: Global Diagnostic Specialty Antibodies Market Attractiveness, by Region, 2018–2026
Figure 35: North America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026 
Figure 36: North America Diagnostic Specialty Antibodies Market Value Share, by Country, 2018 and 2026
Figure 37: North America Diagnostic Specialty Antibodies Market Attractiveness, by Country, 2018–2026
Figure 38: North America Diagnostic Specialty Antibodies Market Value Share, by Antibody Type, 2018 and 2026
Figure 39: North America Diagnostic Specialty Antibodies Market Attractiveness, by Antibody Type, 2018–2026
Figure 40: North America Diagnostic Specialty Antibodies Market Value Share, by Application, 2018 and 2026
Figure 41: North America Diagnostic Specialty Antibodies Market Attractiveness, by Application, 2018–2026
Figure 42: North America Diagnostic Specialty Antibodies Market Value Share, by End-user, 2018 and 2026
Figure 43: North America Diagnostic Specialty Antibodies Market Attractiveness, by End-user, 2018–2026
Figure 44: Europe Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 45: Europe Diagnostic Specialty Antibodies Market Value Share, by Country/Sub-region, 2018–2026
Figure 46: Europe Diagnostic Specialty Antibodies Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 47: Europe Diagnostic Specialty Antibodies Market Value Share, by Antibody Type, 2018 and 2026
Figure 48: Europe Diagnostic Specialty Antibodies Market Attractiveness, by Antibody Type, 2018–2026
Figure 49: Europe Diagnostic Specialty Antibodies Market Value Share, by Application, 2018 and 2026
Figure 50: Europe Diagnostic Specialty Antibodies Market Attractiveness, by Application, 2018–2026
Figure 51: Europe Diagnostic Specialty Antibodies Market Value Share, by End-user, 2018 and 2026
Figure 52: Europe Diagnostic Specialty Antibodies Market Attractiveness, by End-user, 2018–2026
Figure 53: Asia Pacific Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 54: Asia Pacific Diagnostic Specialty Antibodies Market Value Share, by Country/Sub-region, 2018–2026
Figure 55: Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 56: Asia Pacific Diagnostic Specialty Antibodies Market Value Share, by Antibody Type, 2018 and 2026
Figure 57: Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness, by Antibody Type, 2018–2026
Figure 58: Asia Pacific Diagnostic Specialty Antibodies Market Value Share, by Application, 2018 and 2026
Figure 59: Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness, by Application, 2018–2026
Figure 60: Asia Pacific Diagnostic Specialty Antibodies Market Value Share, by End-user, 2018 and 2026
Figure 61: Asia Pacific Diagnostic Specialty Antibodies Market Attractiveness, by End-user, 2018–2026
Figure 62: Latin America Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 63: Latin America Diagnostic Specialty Antibodies Market Value Share, by Country/Sub-region, 2018–2026
Figure 64: Latin America Diagnostic Specialty Antibodies Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 65: Latin America Diagnostic Specialty Antibodies Market Value Share, by Antibody Type, 2018 and 2026
Figure 66: Latin America Diagnostic Specialty Antibodies Market Attractiveness, by Antibody Type, 2018–2026
Figure 67: Latin America Diagnostic Specialty Antibodies Market Value Share, by Application, 2018 and 2026
Figure 68: Latin America Diagnostic Specialty Antibodies Market Attractiveness, by Application, 2018–2026
Figure 69: Latin America Diagnostic Specialty Antibodies Market Value Share, by End-user, 2018 and 2026
Figure 70: Latin America Diagnostic Specialty Antibodies Market Attractiveness, by End-user, 2018–2026
Figure 71: Middle East & Africa Diagnostic Specialty Antibodies Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 72: Middle East & Africa Diagnostic Specialty Antibodies Market Value Share, by Country/Sub-region, 2018–2026
Figure 73: Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 74: Middle East & Africa Diagnostic Specialty Antibodies Market Value Share, by Antibody Type, 2018 and 2026
Figure 75: Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness, by Antibody Type, 2018–2026
Figure 76: Middle East & Africa Diagnostic Specialty Antibodies Market Value Share, by Application, 2018 and 2026
Figure 77: Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness, by Application, 2018–2026
Figure 78: Middle East & Africa Diagnostic Specialty Antibodies Market Value Share, by End-user, 2018 and 2026
Figure 79: Middle East & Africa Diagnostic Specialty Antibodies Market Attractiveness, by End-user, 2018–2026

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *